Anti-IL-8 antibody [EPR22994-255]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal IL-8 antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
IL8, CXCL8, Interleukin-8, IL-8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8, Emoctakin, Granulocyte chemotactic protein 1, Monocyte-derived neutrophil chemotactic factor, Monocyte-derived neutrophil-activating peptide, Neutrophil-activating protein 1, Protein 3-10C, T-cell chemotactic factor, GCP-1, MDNCF, MONAP, NAP-1
- WB
Lab
Western blot - Anti-IL-8 antibody [EPR22994-255] (AB235584)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 3 minutes
All lanes:
Western blot - Anti-IL-8 antibody [EPR22994-255] (ab235584) at 1/1000 dilution
Lane 1:
U-87 MG (human glioblastoma-astrocytoma epithelial cell), whole cell lysate at 40 µg
Lane 2:
U-87 MG treated with 1μM Thapsigargin for 24 hours, whole cell lysate at 40 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 11 kDa
Observed band size: 11 kDa
false
- WB
Lab
Western blot - Anti-IL-8 antibody [EPR22994-255] (AB235584)
Lanes 1 - 6 : Merged signal (red and green). Green - ab235584 observed at 10 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab235584 was shown to react with IL-8 in wild-type PC-3 cells in Western blot with loss of signal observed in CXCL8 knockout cell line ab273743 (knockout cell lysate ab275520). Wild-type PC-3 and CXCL8 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab235584 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-IL-8 antibody [EPR22994-255] (ab235584) at 1/1000 dilution
Lane 1:
Wild-type PC-3 Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 μg/ml, 5 h) cell lysate at 30 µg
Lane 2:
Wild-type PC-3 LPS-treated (2 μg/ml, 6 h) with Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) (5 μg/ml, 5 h) cell lysate at 30 µg
Lane 2:
Western blot - Human CXCL8 knockout PC-3 cell line (<a href='/en-us/products/cell-lines/human-cxcl8-knockout-pc-3-cell-line-ab273743'>ab273743</a>)
Lane 3:
CXCL8 knockout PC-3 Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 μg/ml, 5 h) cell lysate at 30 µg
Lane 4:
CXCL8 knockout PC-3 LPS-treated (2 μg/ml, 6 h) with Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) (5 μg/ml, 5 h) cell lysate at 30 µg
Lane 5:
A431 cell lysate at 30 µg
Lane 6:
HCT116 cell lysate at 30 µg
Predicted band size: 11 kDa
Observed band size: 10 kDa
false
- WB
Lab
Western blot - Anti-IL-8 antibody [EPR22994-255] (AB235584)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 3 minutes
All lanes:
Western blot - Anti-IL-8 antibody [EPR22994-255] (ab235584) at 1/1000 dilution
All lanes:
His-tagged human recombiant IL-8 protein (aa21-99) 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 11 kDa
Observed band size: 11 kDa
false
Related conjugates and formulations (1)
-
Anti-IL-8 antibody [EPR22994-255] - BSA and Azide free
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-8 functions as a chemoattractant for neutrophils and lymphocytes facilitating their movement towards the site of infection or injury. It does not form part of a larger protein complex but operates individually to enhance immune cell migration. IL-8 possesses unique binding motifs allowing it to interact with specific receptors namely CXCR1 and CXCR2 on target cells. This binding triggers cellular responses leading to effective immune surveillance and response to inflammatory stimuli.
Pathways
IL-8 operates within important inflammatory and immune response pathways. It forms a part of the NF-κB signaling cascade which activates in response to stress signals promoting the expression of other inflammatory mediators. Additionally it engages in the mitogen-activated protein kinase (MAPK) pathway influencing cellular responses such as proliferation and differentiation. The interaction of IL-8 with these pathways highlights its role in modulating immune responses and highlights its interaction with other proteins such as TNF-α and IL-1β.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Communications biology 6:516 PubMed37179352
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 13:58 PubMed35123547
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in bioengineering and biotechnology 9:779018 PubMed34917601
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 8:682367 PubMed34179086
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com